Dr. Ece is an associate professor of Chemistry at Biruni University. He received a B.Sc. in chemistry at Hacettepe University, Ankara. He completed his master degree in organic chemistry and obtained his Ph.D. in the field of organic, computational medicinal chemistry in the same institution. He worked as Research Assistant between 2002 and 2011 at Hacettepe University.

Dr. Ece gave several talks as invited speaker in international/national scientific organizations including NATO-ASI Summer School, Training Courses etc. He organizes Hands-On Training Courses on Computer Aided Drug Design.

He received two successive awards from Trinity College Dublin in 2017 and 2018. He serves as associate editor for BMC Chemistry journal by Springer Nature.

His research group (ECE Research) is mainly focused on the computer aided drug design & discovery. In that aspect, he uses both quantum chemical and molecular mechanics calculations. Supported by the leading software companies in the field, Ece Research uses effective and specialized computational tools to address a particular problem or to enlight an experimental finding in medicinal, organic or pharmaceutical chemistry.

He believes that there is no boundaries in different fields of sciences. Scientists should set aside the differences and collaborate with each other. It is the reason that the motto of ECE Research is "Combining Multidisciplinary Research".

E-mail: aece@biruni.edu.tr
Web Page: http://www.ece.biruni.edu.tr/

Helen Sheridan B. Sc (UCD), PhD (UCD) is Associate Professor in Pharmacognosy and former Director of Research at the School of Pharmacy and Pharmaceutical Sciences (SoPPS) at Trinity College Dublin. She is an academic founder and director of the TCD centre for natural product research, NatPro. She is a Fellow of Trinity College Dublin and the Royal Society of Chemistry; a recipient of the TCD Provost’s award for teaching excellence and a recipient of the TCD Innovation Award for 'Societal Impact'. Helen has 86 publications including 7 international patents. She has graduated 33 PhD/ MSc students, and mentored 24 postdoctoral researchers. She currently has sixteen researchers in her group. She was awarded €19 million in grant income from national and international sources. Helen's collaborative and interdisciplinary research is in Natural Product (NP) chemistry; Traditional Medicine (TM); ethnopharmacology; global health and bioeconomy. Her research focusses on finding new therapies for disease and addressing global issues that may be resolved using NP approaches. During her career she identified a lead molecule from TM which her team advanced from discovery to human clinical trials. Helen co-founded the TCD Campus company, Trino Therapeutics Ltd, where she was co-PI on funding of approximately €13 million. She was also co-applicant on seven patents in the US, EU and Asia. In later years Helen has become involved in global ethnopharmacology, investigating quality, safety and efficacy of TMs, and the link between the established use of TM and its role in international development. She has supervised 5 research projects in sub-Saharan Africa. Helen was recently awarded €6M to direct a project entitled “Unlocking Nature’s Pharmacy from Bogland Species” focused on the therapeutic and economic potential of the Irish bog land plants, from scientific and educational perspectives. She is a collaborator on a further successful €3.5m award to be announced Feb 2022. Helen is the Phytochemical expert to the Irish Health Products Regulatory Authority (HPRA). She is on the Board of the International Natural Product Sciences taskforce (INPST); was elected to the Board of the GP-TCM Research Association; and most recently was appointed by the Cross-Government Bioeconomy Implementation Group (BIG) to the Expert Advisory Group, as the expert in NP science, to support the National Bioeconomy Forum. Helen holds a TCD award for excellence in teaching. She has taught at all levels across the SoPPS curriculum and has contributed to courses across faculties. Her teaching is research led, maps frontier developments, is informed by government policy and international regulation, and is aligned with global development goals. Her course design and delivery involve synergy at the interfaces governing her discipline. She has recently been funded by the IRC ‘New Foundations’ scheme, to build educational and research collaborations between TCD, and Maseno University (Kenya). Helen has held senior administrative positions in College, including Director of Research SoPPS (2016-9); Academic Disability Liaison Officer (2006-To date); positions in safety at school, faculty and college level and is the faculty representative on the College Safety Committee. She was faculty representative on the Trinity International Development Initiative steering committee. Helen has acted as external examiner to the School of Pharmacy in UCL (2015-8); has examined at masters and PhD level nationally and globally; has acted as an international grant reviewer on several programmes. Helen is engaged in outreach with a range of stakeholders. Most recently she and her group have launched a national programme for Transition Year students looking at biodiversity, scientific and commercial potential of bogland ecosystems. Helen drives her research, teaching, and outreach toward mankind a difference to society. Helen was recently awarded the TCD Innovation Award for Societal Impact.

E-mail: hsheridn@tcd.ie
Web Page: http://www.pharmacy.tcd.ie/staff/sheridan-cv.php

Faika Basoglu-Ünal is an Assistant Professor at European University of Lefke at the Faculty of Pharmacy since 2021. Basoglu-Ünal completed her Ph.D. in Pharmaceutical Chemistry (Experimental Thesis: Novel imidazo[2,1-b]thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation) at Istanbul University and concurrently she has been gone to University of Florida as a visiting researcher for 6 months. During this period, she has worked on potent antibacterial targeting, biofilm eradication, and prodrug exploration for some halogenated phenazine derivatives.
Research interests:
1. Anticancer Drug Discovery & Design
2. Computational Chemistry & Cheminformatics
Professional Memberships:
1. Member of American Chemical Society (ACS)

E-mail: fabasoglu@eul.edu.tr

Veysel Kocabey has more than 16 years of quality control experience on pharmaceutical industry with raw materials, finished products and stability testing. He received a B.Sc. in chemistry at Hacettepe University, Ankara.

He worked at PharmaVision Pharmaceutical Industry Co. Inc. as IPC Analyst, Quality Control Analyst (Raw Material), Quality Control Expert Analyst (Raw Material) and finally as Quality Control Raw Material Supervisor (Team Leader), from 2006 to 2013. He then continued his career at Biofarma Pharmaceutical Industry Co. Inc. as “Quality Control Executive” between 2014 and 2017. He worked at Bilim Pharmaceutical Industry Co. Inc. as Quality Control Executive between 2017 to 2018. He then started at Nukleon Nuclear Technology Research Ind. Co. Ltd (Radiopharmaceutical Industry) and worked as Quality Control Manager from 2018 to 2020.

During his career at those pharmaceutical companies, he had a critical role in international audits such audits carried out by UCB, Abbott, Johnson&Johnson as well by European Health Authorities (Ministry of Social Affairs and Health (France), The Federal Ministry of Health (Germany), Belupo (Croatia's second largest pharmaceutical company), MHRA – UK Health Authority, PharOS (Greece).

E-mail: veysel.kocabey@demilac.com.tr

He received B.Sc. degree in chemistry in 1995, from Department of Chemistry, Ankara University. He then completed his master's degree in Analytical Chemistry at the same university. He career is in drug industry where he worked as QC Supervisor (Eczacıbaşı, 1998-2006), QC Executive (Sanovel, 2006-2011), QC Manager (Worldmedicine, 2011-2013), Quality Operation Manager, Qualified Person (Biofarma, 2013-2019), Qualified Person (Dem İlaç, 2019 - 2021). He has been working at Analitik Kimya ve Lab.Cihazları Ltd.Şti. as Head of Sales and Marketing Department since 2021.

E-mail: erkan@analitikkimya.com.tr

Arooma Maryam is working as a Post doctoral Associate in UMASS Chan Medical School,Worcester, MA, US. She obtained her PhD degree in Biosciences from Comsats University Islamabad, Pakistan. Her PhD research work was focused on the prediction of high-order domain assembly and effects of mutations on the structural stability of of PDE6 and PKGI. She further explored conformational heterogeneity of PKGI using structural bioinformatics tools. During her PhD, she worked in Department of Biochemistry, University of Cambridge, UK, Lab,Institute of Molecular Cell & Systems Biology, University of Glasgow, UK, Scotland, UK and Computer-Aided Drug Design Center Biruni University, Istanbul-Turkey.

Research interests

Suleyman Selim Cinaroglu is a DPhil student at the University of Oxford at the Department of Biochemistry since 2019. He obtained his bachelor's degree in Molecular Biology and Genetics, afterwards completed his M.Sc. in Medical Biotechnology at Acibadem University. Then, he joined Eternans Biotechnology LTD. as a bioinformatician and performed molecular modelling studies for the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells.

He is mainly interested in the research areas including atomistic-scale simulations and computer-aided drug discovery, and the design of new therapeutic agents like peptides and small molecules.